Expertise in
3
conditions

Oliver Riesterer

Aarau, AG, CH 
Expertise in
3
conditions
Aarau, AG, CH 

Overview

Oliver Riesterer practices practicing medicine in Aarau, Switzerland.

Mr. Riesterer is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Mesothelioma, Head and Neck Squamous Cell Carcinoma (HNSCC), Lung Metastases, and Lung Cancer.

He is actively involved in clinical research, co-authoring 99 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Aarau, AG, Switzerland
Other Locations
Réseau hospitalier neuchâtelois
Neuchatel, NE, Switzerland
Kantonsspital Graubünden
Chur, GR, Switzerland
Kantonsspital Winterthur
Winterthur, ZH, Switzerland
Zurich, ZH, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Transarterial Chemoembolization With Drug-Eluting Beads (Standard Arm) Versus Stereotactic Body Radiation Therapy (Experimental Arm) for Hepatocellular Carcinoma: A Multicenter Randomized Phase II Trial
Transarterial Chemoembolization With Drug-Eluting Beads (Standard Arm) Versus Stereotactic Body Radiation Therapy (Experimental Arm) for Hepatocellular Carcinoma: A Multicenter Randomized Phase II Trial
Enrollment Status: Terminated
Publish Date: January 27, 2021
Intervention Type: Radiation, Device
Study Phase: Phase 2
View 1 Less Clinical Trial

99 Total Publications

Probabilistic modelling of bilateral lymphatic spread in oral cavity squamous cell carcinoma for personalised elective nodal treatment.
Probabilistic modelling of bilateral lymphatic spread in oral cavity squamous cell carcinoma for personalised elective nodal treatment.
Journal: Physics in medicine and biology
Published: January 13, 2026

Frequently Asked Questions about Oliver Riesterer

Is Oliver Riesterer a top-rated expert for Mesothelioma?

MediFind is an objective health platform that identifies experts based on real-world data. Oliver Riesterer is classified as an Advanced expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Oliver Riesterer participate in research or clinical trials?

Yes. Oliver Riesterer has published 99 articles and abstracts on conditions like Mesothelioma. You can view a list of Oliver Riesterer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Riesterer's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile